share_log

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Avenue Therapeutics | 4：持股變動聲明-股東 Fortress Biotech, Inc.
美股sec公告 ·  04/18 04:10
牛牛AI助理已提取核心訊息
Fortress Biotech, Inc., reported a completed transaction involving the acquisition of 413,507 shares of common stock in Avenue Therapeutics, Inc. (ATXI) on April 16, 2024. The shares were granted at no cost, as indicated by a transaction price of $0.00. Following this transaction, Fortress Biotech's direct holdings in Avenue Therapeutics increased to a total of 3,547,393 shares. The nature of the transaction was described as a grant, award, or other acquisition, according to the transaction code 'A'. This event reflects a significant increase in Fortress Biotech's stake in the pharmaceutical company.
Fortress Biotech, Inc., reported a completed transaction involving the acquisition of 413,507 shares of common stock in Avenue Therapeutics, Inc. (ATXI) on April 16, 2024. The shares were granted at no cost, as indicated by a transaction price of $0.00. Following this transaction, Fortress Biotech's direct holdings in Avenue Therapeutics increased to a total of 3,547,393 shares. The nature of the transaction was described as a grant, award, or other acquisition, according to the transaction code 'A'. This event reflects a significant increase in Fortress Biotech's stake in the pharmaceutical company.
Fortress Biotech, Inc. 報告稱，一項交易已於2024年4月16日完成，涉及收購Avenue Therapeutics, Inc.（ATXI）413,507股普通股。這些股票是免費授予的，交易價格爲0.00美元。在這筆交易之後，豐澤生物科技在Avenue Therapeutics的直接持股量增加到總共3547,393股。根據交易代碼 “A”，該交易的性質被描述爲贈款、獎勵或其他收購。該事件反映了豐澤生物科技在這家制藥公司的股份大幅增加。
Fortress Biotech, Inc. 報告稱，一項交易已於2024年4月16日完成，涉及收購Avenue Therapeutics, Inc.（ATXI）413,507股普通股。這些股票是免費授予的，交易價格爲0.00美元。在這筆交易之後，豐澤生物科技在Avenue Therapeutics的直接持股量增加到總共3547,393股。根據交易代碼 “A”，該交易的性質被描述爲贈款、獎勵或其他收購。該事件反映了豐澤生物科技在這家制藥公司的股份大幅增加。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。